Report Date,2012-03-31 00:00:00,2013-03-31 00:00:00,2014-03-31 00:00:00,2015-03-31 00:00:00,2016-03-31 00:00:00,2017-03-31 00:00:00,2018-03-31 00:00:00,2019-03-31 00:00:00,2020-03-31 00:00:00,2021-03-31 00:00:00,Company_Name
Cash from Operating Activity,7.08,12.05,7.52,4.3,9.04,-3.24,-1.58,30.9,11.89,28.22,JAGSNPHARM
Cash from Investing Activity,-4.94,-3.4,-1.21,-0.46,-2.09,41.29,-3.37,-0.83,-11.07,-2.26,JAGSNPHARM
Cash from Financing Activity,0.41,-8.19,-4.05,-1.42,-6.43,-33.52,-0.6,-6.05,-1.82,-6.83,JAGSNPHARM
Net Cash Flow,2.55,0.46,2.26,2.41,0.52,4.53,-5.55,24.02,-1.01,19.13,JAGSNPHARM
